BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12393513)

  • 1. Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage.
    Haberichter SL; Jacobi P; Montgomery RR
    Blood; 2003 Feb; 101(4):1384-91. PubMed ID: 12393513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The von Willebrand factor propeptide (VWFpp) traffics an unrelated protein to storage.
    Haberichter SL; Jozwiak MA; Rosenberg JB; Christopherson PA; Montgomery RR
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):921-6. PubMed ID: 12067899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
    Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
    Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor storage and multimerization: 2 independent intracellular processes.
    Haberichter SL; Fahs SA; Montgomery RR
    Blood; 2000 Sep; 96(5):1808-15. PubMed ID: 10961880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention.
    Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J
    Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells.
    Royo T; Martínez-González J; Vilahur G; Badimon L
    Atherosclerosis; 2003 Mar; 167(1):55-63. PubMed ID: 12618268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.
    Madabhushi SR; Shang C; Dayananda KM; Rittenhouse-Olson K; Murphy M; Ryan TE; Montgomery RR; Neelamegham S
    Blood; 2012 May; 119(20):4769-78. PubMed ID: 22452980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Roles of the von Willebrand Factor Propeptide.
    Rawley O; Lillicrap D
    Hamostaseologie; 2021 Feb; 41(1):63-68. PubMed ID: 33588457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.
    Haberichter SL; Budde U; Obser T; Schneppenheim S; Wermes C; Schneppenheim R
    Blood; 2010 Jun; 115(22):4580-7. PubMed ID: 20335223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP).
    Olsen EH; McCain AS; Merricks EP; Fischer TH; Dillon IM; Raymer RA; Bellinger DA; Fahs SA; Montgomery RR; Keith JC; Schaub RG; Nichols TC
    Blood; 2003 Jul; 102(2):436-41. PubMed ID: 12649145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-mediated in vitro processing of pro-von Willebrand factor.
    Váradi K; Turecek PL; Mitterer A; Dorner F; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1449-58. PubMed ID: 11776313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF.
    Rosenberg JB; Haberichter SL; Jozwiak MA; Vokac EA; Kroner PA; Fahs SA; Kawai Y; Montgomery RR
    Blood; 2002 Sep; 100(5):1699-706. PubMed ID: 12176890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.
    Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A
    Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.
    Sztukowska M; Gallinaro L; Cattini MG; Pontara E; Sartorello F; Daidone V; Padrini R; Pagnan A; Casonato A
    Br J Haematol; 2008 Oct; 143(1):107-14. PubMed ID: 18691167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granules.
    Swinkels M; Hordijk S; Bürgisser PE; Slotman JA; Carter T; Leebeek FWG; Jansen AJG; Voorberg J; Bierings R
    J Thromb Haemost; 2023 Jul; 21(7):1967-1980. PubMed ID: 37061132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage.
    Haberichter SL; Allmann AM; Jozwiak MA; Montgomery RR; Gill JC
    J Thromb Haemost; 2009 Apr; 7(4):641-50. PubMed ID: 19192112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.
    Casonato A; Sartorello F; Cattini MG; Pontara E; Soldera C; Bertomoro A; Girolami A
    Blood; 2003 Jan; 101(1):151-6. PubMed ID: 12393698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
    Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
    J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
    Eikenboom J; Federici AB; Dirven RJ; Castaman G; Rodeghiero F; Budde U; Schneppenheim R; Batlle J; Canciani MT; Goudemand J; Peake I; Goodeve A;
    Blood; 2013 Mar; 121(12):2336-9. PubMed ID: 23349392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.